DBVT — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
France
Last close
$14.14
Market Cap
$888.64M
52W High
$19.81
52W Low
$13.00
ADV30
335,685
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -50,600,000 | -50,400,000 | 223,200,000 | 174,900,000 | 62,800,000 |
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
| Sep 2025 | 0 | — | -34,277,000 | -33,164,000 | 110,495,000 | 69,837,000 | 57,641,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-168,983,000
Investing CF
$-1,869,000
Financing CF
$248,182,000
CapEx
$-1,296,000
Dividends Paid
—
Buybacks
$-159,000
EPS Diluted TTM
$-3.90
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-270,300,000
Inventory
—
Receivables
$17,300,000
ST Investments
—
EBIT TTM
$-177,825,000
Pretax Income TTM
$-175,219,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,036,000
EBITDA
$-174,762,000
Free Cash Flow
$-104,847,504
Enterprise Value
$669,648,128
Total Cash
$174,900,000
Total Debt
$7,700,000
Shares Out
62,845,812
Trailing EPS
$-3.37
Book Value
$2.71
ROE
-142.7%
ROA
-60.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | — | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | — | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | — | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | — | -55,666,000 |
TTM Snapshot
Revenues TTM
$7,066,000
NetIncome TTM
$-99,704,000
OpCashFlow TTM
$0
Assets (Latest)
$65,658,000
Forward EPS
$-0.54
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $14.94 · call volume: 3 · put volume: 2
Expected Move to 2027-02-19:
±$6.93
(46.35%) —
implied range
$8.01 –
$21.86
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | $850.21M | $15.39 | — |
| AURA | Aura Biosciences, Inc. | $819.27M | $7.90 | — |
| SLDB | Solid Biosciences Inc. | $982.18M | $9.16 | — |
| CADL | Candel Therapeutics, Inc. | $984.03M | $12.86 | — |
| TECX | Tectonic Therapeutic, Inc. | $712.97M | $36.47 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading
2026-08-10 15:16 · Yahoo
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
2026-07-27 14:31 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
2026-08-25 15:15 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
2026-08-20 15:17 · Yahoo
European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading
2026-08-18 15:13 · Yahoo
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
2026-08-17 15:12 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
2026-08-05 15:12 · Yahoo
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
2026-07-30 21:40 · Yahoo
European Equities Traded in US as ADRs Ease in Tuesday Trading
2026-07-28 15:04 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
2026-07-24 15:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.